Entero Healthcare IPO is a book-built issue of Rs 1,600.00 crores. The issue is a combination of a fresh issue of 0.79 crore shares aggregating to Rs 1,000.00 crores and an offer for sale of 0.48 crore shares aggregating to Rs 600.00 crores.

Entero Healthcare IPO opens for subscription on February 9, 2024, and closes on February 13, 2024. The allotment for the Entero Healthcare Solutions IPO is expected to be finalized on Wednesday, February 14, 2024. Entero Healthcare Solutions IPO will list on BSE, and NSE with a tentative listing date fixed as Friday, February 16, 2024.

Entero Healthcare  IPO Timeline (Tentative Schedule)
Entero Healthcare Solutions IPO opens on February 9, 2024, and closes on February 13, 2024.

IPO Open Date Friday, February 9, 2024
IPO Close Date Tuesday, February 13, 2024
Basis of Allotment Wednesday, February 14, 2024
Initiation of Refunds Thursday, February 15, 2024
Credit of Shares to Demat Thursday, February 15, 2024
Listing Date Friday, February 16, 2024
The cut-off time for UPI mandate confirmation is 5 PM on February 13, 2024

Entero Healthcare Solutions IPO price band is set at ₹1195 to ₹1258 per share. The minimum lot size for an application is 11 Shares. The minimum amount of investment required by retail investors is ₹13,838. The minimum lot size investment for sNII is 15 lots (165 shares), amounting to ₹207,570, and for bNII, it is 73 lots (803 shares), amounting to ₹1,010,174.
Entero Healthcare Solutions IPO Lot Size
Investors can bid for a minimum of 11 shares and in multiples thereof. The table below depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amounts.

Application Lots Shares Amount
Retail (Min) 1 11 ₹13,838
Retail (Max) 14 154 ₹193,732
S-HNI (Min) 15 165 ₹207,570
S-HNI (Max) 72 792 ₹996,336
B-HNI (Min) 73 803 ₹1,010,174

About Entero Healthcare Solutions Limited
Incorporated in 2018, Entero Healthcare Solutions Limited distributes healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.

During the fiscal years 2021, 2022, and 2023, the company served over 39,500, 64,200, and 81,400 retail customers, respectively. They also served over 1,600, 2,500, and 3,400 hospital customers during the same period.

Entero Healthcare Solutions has relationships with over 1,900 healthcare product manufacturers, giving them access to over 64,500 product stock-keeping units as of March 31, 2023.

The company has 73 warehouses in 37 cities across 19 states and union territories, and its customer base includes over 81,400 pharmacies and 3,400 hospitals in 495 districts as of March 31, 2023. This provides excellent access to healthcare product manufacturers.

Objects of the Issue (Entero Healthcare Solutions IPO Objectives)
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:

Repayment/prepayment, in full or part, of certain borrowings availed of by the company and our Subsidiaries.
Funding the long-term working capital requirements.
Pursuing inorganic growth initiatives through acquisitions.
General corporate purposes.

#upcomingipo2024 
#ipo 
#enterohealthcareipo
#ipolisting 
#iponewslatest 
#ipoapply 
#ShouldyoubuyIPOsonlistingday?
#investinipoonlistingday
#buy 
#buyback 
#buybackipoonlistingday
#buyipoafter1year
#valueresearch 


ipo listing data
ipo profits data
latest ipo news
ipo latest news
upcoming ipo
initial public offering
stock market
stock market news

For Any Query Call @ +91 9368710882
Open 100% Free Paperless Demat Account @ http://bit.ly/2OuyXNJ
For more Info Visit @ http://bit.ly/33yTc0V

Visit @ https://rmoneyindia.com/
Facebook @ https://www.facebook.com/raghunandanmoneyindia
Twitter @ https://twitter.com/Rmoneyindia
Linkedin @ https://www.linkedin.com/company/3580395/admin/